Reports Q4 revenue $22.418M, consensus $20.82M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPTN:
- Optinose downgraded to Neutral from Buy at H.C. Wainwright
- Optinose downgraded to Neutral from Overweight at Piper Sandler
- Hold Rating Issued Amid Optinose Acquisition by Paratek Pharmaceuticals with Adjusted Price Target
- Optinose downgraded to Hold from Buy at Lake Street
- Paratek Pharmaceuticals to acquire Optinose in $330M transaction
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue